Skip to main content
GutCited

Figure 8

Chart
830 × 1140px · 191.0 केबी 

Source Paper

Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review.

Nutrients (2023)

PMID: 37242159

DOI: 10.3390/nu15102275

Cite This Figure

![Figure 8: Clinical evidence from intervention studies suggests that butyrate supplementation, either orally or via enema, may reduce disease activity scores in ulcerative colitis patients. Response rates vary across delivery methods and formulations.](https://pdfs.citedhealth.com/figures/37242159/105.png)

> Source: Neeraja Recharla et al. "Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel." *Nutrients*, 2023. PMID: [37242159](https://pubmed.ncbi.nlm.nih.gov/37242159/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/37242159/105.png" alt="Clinical evidence from intervention studies suggests that butyrate supplementation, either orally or via enema, may reduce disease activity scores in ulcerative colitis patients. Response rates vary across delivery methods and formulations." />
  <figcaption>Figure 8. Clinical evidence from intervention studies suggests that butyrate supplementation, either orally or via enema, may reduce disease activity scores in ulcerative colitis patients. Response rates vary across delivery methods and formulations.<br>  Source: Neeraja Recharla et al. "Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel." <em>Nutrients</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37242159/">37242159</a></figcaption>
</figure>